# GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

> **NCT04121273** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 20 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** CAR-T cell immunotherapy

## Key facts

- **NCT ID:** NCT04121273
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-05
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121273, "GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04121273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*